The Fellow on Call: The Heme/Onc Podcast cover image

Episode 098: Understanding MRD Testing in CLL

The Fellow on Call: The Heme/Onc Podcast

00:00

Understanding Measurable Residual Disease in CLL

This chapter explores Measurable Residual Disease (MRD) and its crucial role in assessing residual cancer cells post-treatment. It discusses detection methods like flow cytometry and molecular techniques, along with the clinical implications of MRD status in chronic lymphocytic leukemia.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app